Accueil / Communiqués / The Bioinformatics Infrastructure Congress launches in Boston on May 7-9, 2019

The Bioinformatics Infrastructure Congress launches in Boston on May 7-9, 2019

Friday, March 15th 2019 at 10:30am UTC

BOSTON–(BUSINESS WIRE)– The Bioinformatics
Infrastructure Congress
is the first bioinformatics
conference that is solely focussed on tools and unit set-up, rather than
application. Join 100+ senior IT, data and informatics professionals
looking to modernize research infrastructure for life sciences.

The volume of biological data available to drug companies today requires
increasingly sophisticated tools for storage, sharing and analysis.
Machine learning, cloud, data commons and quantum computing all offer
important discovery prospects for in silico units. But they also present
problems such as build vs buy debate, overcoming cultural differences
between biologists and data scientists, standardization and
interoperability challenges. The Bioinformatics Infrastructure Congress
enables IT and computational biology heads from pharma, biotech and
academia to explore how to implement new tools and optimize data
storage, security, visualization and analysis.

Case studies to be discussed include the Broad Institute’s Dr Anthony
Philippakis on how to take best-practice from the tech sector to set up
a best-in-class data management centre, the NIH’s Vivien Bonazzi on
progress from the NIH Data Commons Pilot Phase and plans for the
immediate future as well as MedImmune’s Dr David Fenstermacher on how to
integrate data at high volumes so that it is still usable within an
organisation.

The congress also features a dedicated Machine Learning Day on Tuesday,
May 7th. As drug companies, researchers and health providers
update their data management infrastructure the use of Machine Learning
tools in life sciences is finally here. The Machine Learning Day takes
participants beyond the “what if” and explores how AI and other advanced
analytic tools are being used today.

Hear from Dr Ramesh Dursuvala, Vice President and Information Officer,
Research Labs on addressing bottlenecks in data collection and
standardisation to train ML systems at Eli Lilly; Dr Kelly Zou, Vice
President, Head of Medical Analytics and Insights, R&D and Medical,
Upjohn Division on changing clinical trial design and execution using
algorithms at Pfizer and Mason Victors, Chief Technology Officer on
implementing custom data-build to programme an AI for compound discovery
and first steps in the clinic at Recursion Pharmaceuticals.

Register
to attend before April 5, 2019 to save up to $300 with early bird
pricing.

To find out more, visit www.bioinformaticsusa.com

Contacts

Press contact for Bioinformatics Infrastructure USA:
Finola
McMahon
Marketing Manager, Kisaco Research
fm@kisacoresearch.com
+44
(0)203 696 2922

Source: Kisaco Research


Voir aussi

Innovations in Artificial Intelligence, Blockchain, Quantum Computing, Robots, and Catalysts, 2019 Study – ResearchAndMarkets.com

Friday, March 22nd 2019 at 3:01pm UTC DUBLIN–(BUSINESS WIRE)– The « Innovations in Artificial Intelligence, Blockchain, …